Obesity-induced increases in sympathetic nerve activity: Sex matters

Autonomic Neuroscience: Basic and Clinical

Volumn 187, Issue , 2015, Pages 18-26

  Brooks, Virginia L ^a   Shi, Zhigang ^a   Holwerda, Seth W ^b   Fadel, Paul J ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

Blood pressure; Insulin; Leptin; Sex differences; Vasoconstriction; Visceral obesity

Indexed keywords

ADIPONECTIN; ANGIOTENSIN II; ESTROGEN; INSULIN; LEPTIN; NORADRENALIN; PROGESTERONE;

ADRENERGIC SYSTEM; ARTICLE; BLOOD VESSEL REACTIVITY; BROWN ADIPOSE TISSUE; CARDIOVASCULAR DISEASE; DIET INDUCED OBESITY; FEMALE; HUMAN; HYPERTENSION; INFLAMMATION; INTRAABDOMINAL FAT; MALE; NONHUMAN; NORADRENALIN RELEASE; OBESITY; POSTMENOPAUSE; PREMENOPAUSE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEX DIFFERENCE; SUBCUTANEOUS FAT; SYMPATHETIC TONE; VASCULAR RESISTANCE; VASOCONSTRICTION; WHITE ADIPOSE TISSUE; BLOOD; BLOOD PRESSURE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SEXUAL DEVELOPMENT;

BLOOD PRESSURE; FEMALE; HUMANS; INSULIN; LEPTIN; MALE; OBESITY; SEX CHARACTERISTICS; SYMPATHETIC NERVOUS SYSTEM; VASOCONSTRICTION;

EID: 84920198050     PISSN: 15660702     EISSN: 18727484     Source Type: Journal    
DOI: 10.1016/j.autneu.2014.11.006     Document Type: Article

References (126)

1. Abate N.I., Mansour Y.H., Tuncel M., Arbique D., Chavoshan B., Kizilbash A., Howell-Stampley T., Vongpatanasin W., Victor R.G. Overweight and sympathetic overactivity in black Americans. Hypertension 2001, 38:379-383.
2. Agapitov A.V., Correia M.L., Sinkey C.A., Haynes W.G. Dissociation between sympathetic nerve traffic and sympathetically mediated vascular tone in normotensive human obesity. Hypertension 2008, 52:687-695.
3. Allison M.A., Ix J.H., Morgan C., McClelland R.L., Rifkin D., Shimbo D., Criqui M.H. Higher leptin is associated with hypertension: the Multi-Ethnic Study of Atherosclerosis. J. Hum. Hypertens. 2013, 27:617-622.
4. Almeida-Pititto B., Gimeno S.G., Freire R.D., Ribeiro-Filho F.F., Ferreira S.R. Leptin is not associated independently with hypertension in Japanese-Brazilian women. Braz. J. Med. Biol. Res. 2006, 39:99-105.
5. Alvarez G.E., Beske S.D., Ballard T.P., Davy K.P. Sympathetic neural activation in visceral obesity. Circulation 2002, 106:2533-2536.
6. Alvarez G.E., Ballard T.P., Beske S.D., Davy K.P. Subcutaneous obesity is not associated with sympathetic neural activation. Am. J. Physiol. Heart Circ. Physiol. 2004, 287:H414-H418.
7. Amador N., Guizar J.M., Malacara J.M., Perez-Luque E., Paniagua R. Sympathetic activity and response to ACE inhibitor (enalapril) in normotensive obese and non-obese subjects. Arch. Med. Res. 2004, 35:54-58.
8. Armitage J.A., Burke S.L., Prior L.J., Barzel B., Eikelis N., Lim K., Head G.A. Rapid onset of renal sympathetic nerve activation in rabbits fed a high-fat diet. Hypertension 2012, 60:163-171.
9. Banks W.A. The source of cerebral insulin. Eur. J. Pharmacol. 2004, 490:5-12.
10. Banks W.A., Jaspan J.B., Huang W., Kastin A.J. Transport of insulin across the blood-brain barrier: saturability at euglycemic doses of insulin. Peptides 1997, 18:1423-1429.
11. Banks W.A., Jaspan J.B., Kastin A.J. Selective, physiological transport of insulin across the blood-brain barrier: novel demonstration by species-specific radioimmunoassays. Peptides 1997, 18:1257-1262.
12. Bardgett M.E., Stocker S.D. Diet-induced obesity causes selective insulin resistance. FASEB J. 2010, 24:809.23.
13. Bardgett M.E., McCarthy J.J., Stocker S.D. Glutamatergic receptor activation in the rostral ventrolateral medulla mediates the sympathoexcitatory response to hyperinsulinemia. Hypertension 2010, 55:284-290.
14. Barnes J.N., Hart E.C., Curry T.B., Nicholson W.T., Eisenach J.H., Wallin B.G., Charkoudian N., Joyner M.J. Aging enhances autonomic support of blood pressure in women. Hypertension 2014, 63:303-308.
15. Belin de Chantemele E.J., Mintz J.D., Rainey W.E., Stepp D.W. Impact of leptin-mediated sympatho-activation on cardiovascular function in obese mice. Hypertension 2011, 58:271-279.
16. Benedict C., Kern W., Schultes B., Born J., Hallschmid M. Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin. J. Clin. Endocrinol. Metab. 2008, 93:1339-1344.
17. Berne C., Fagius J., Pollare T., Hjemdahl P. The sympathetic response to euglycaemic hyperinsulinaemia. Evidence from microelectrode nerve recordings in healthy subjects. Diabetologia 1992, 35:873-879.
18. Boustany C.M., Bharadwaj K., Daugherty A., Brown D.R., Randall D.C., Cassis L.A. Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 287:R943-R949.
19. Boustany C.M., Brown D.R., Randall D.C., Cassis L.A. AT1-receptor antagonism reverses the blood pressure elevation associated with diet-induced obesity. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 289:R181-R186.
20. Cai D., Liu T. Inflammatory cause of metabolic syndrome via brain stress and NF-kappaB. Aging (Albany NY) 2012, 4:98-115.
21. Carter J.R., Fu Q., Minson C.T., Joyner M.J. Ovarian cycle and sympathoexcitation in premenopausal women. Hypertension 2013, 61:395-399.
22. Cartier A., Cote M., Lemieux I., Perusse L., Tremblay A., Bouchard C., Despres J.P. Sex differences in inflammatory markers: what is the contribution of visceral adiposity?. Am. J. Clin. Nutr. 2009, 89:1307-1314.
23. Cassaglia P.A., Hermes S.M., Aicher S.A., Brooks V.L. Insulin acts in the arcuate nucleus to increase lumbar sympathetic nerve activity and baroreflex function in rats. J. Physiol. 2011, 589:1643-1662.
24. Cassis L.A., Police S.B., Yiannikouris F., Thatcher S.E. Local adipose tissue renin-angiotensin system. Curr. Hypertens. Rep. 2008, 10:93-98.
25. Charkoudian N., Wallin B.G. Sympathetic neural activity to the cardiovascular system: integrator of systemic physiology and interindividual characteristics. Compr. Physiol. 2014, 4:825-850.
26. Charkoudian N., Joyner M.J., Johnson C.P., Eisenach J.H., Dietz N.M., Wallin B.G. Balance between cardiac output and sympathetic nerve activity in resting humans: role in arterial pressure regulation. J. Physiol. 2005, 568:315-321.
27. Christou D.D., Jones P.P., Jordan J., Diedrich A., Robertson D., Seals D.R. Women have lower tonic autonomic support of arterial blood pressure and less effective baroreflex buffering than men. Circulation 2005, 111:494-498.
28. Clegg D.J., Riedy C.A., Smith K.A., Benoit S.C., Woods S.C. Differential sensitivity to central leptin and insulin in male and female rats. Diabetes 2003, 52:682-687.
29. Clegg D.J., Brown L.M., Woods S.C., Benoit S.C. Gonadal hormones determine sensitivity to central leptin and insulin. Diabetes 2006, 55:978-987.
30. Conway J.M., Yanovski S.Z., Avila N.A., Hubbard V.S. Visceral adipose tissue differences in black and white women. Am. J. Clin. Nutr. 1995, 61:765-771.
31. Davy K.P., Orr J.S. Sympathetic nervous system behavior in human obesity. Neurosci. Biobehav. Rev. 2009, 33:116-124.
32. de Kloet A.D., Pati D., Wang L., Hiller H., Sumners C., Frazier C.J., Seeley R.J., Herman J.P., Woods S.C., Krause E.G. Angiotensin type 1a receptors in the paraventricular nucleus of the hypothalamus protect against diet-induced obesity. J. Neurosci. 2013, 33:4825-4833.
33. Despres J.P., Couillard C., Gagnon J., Bergeron J., Leon A.S., Rao D.C., Skinner J.S., Wilmore J.H., Bouchard C. Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study. Arterioscler. Thromb. Vasc. Biol. 2000, 20:1932-1938.
34. Dobrian A.D., Davies M.J., Prewitt R.L., Lauterio T.J. Development of hypertension in a rat model of diet-induced obesity. Hypertension 2000, 35:1009-1015.
35. Dorresteijn J.A., Schrover I.M., Visseren F.L., Scheffer P.G., Oey P.L., Danser A.H., Spiering W. Differential effects of renin-angiotensin-aldosterone system inhibition, sympathoinhibition and diuretic therapy on endothelial function and blood pressure in obesity-related hypertension: a double-blind, placebo-controlled cross-over trial. J. Hypertens. 2013, 31:393-403.
36. Erlingsson S., Herard S., Dahlqvist L.O., Lindstrom T., Lanne T., Borga M., Nystrom F.H. Men develop more intraabdominal obesity and signs of the metabolic syndrome after hyperalimentation than women. Metabolism 2009, 58:995-1001.
37. Esler M., Straznicky N., Eikelis N., Masuo K., Lambert G., Lambert E. Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension 2006, 48:787-796.
38. Ettinger S.M., Silber D.H., Gray K.S., Smith M.B., Yang Q.X., Kunselman A.R., Sinoway L.I. Effects of the ovarian cycle on sympathetic neural outflow during static exercise. J. Appl. Physiol. 1998, 85:2075-2081.
39. Fagius J., Ellerfelt K., Lithell H., Berne C. Increase in muscle nerve sympathetic activity after glucose intake is blunted in the elderly. Clin. Auton. Res. 1996, 6:195-203.
40. Felder R.B. Mineralocorticoid receptors, inflammation and sympathetic drive in a rat model of systolic heart failure. Exp. Physiol. 2010, 95:19-25.
41. Fisher J.P., Young C.N., Fadel P.J. Central sympathetic overactivity: maladies and mechanisms. Auton. Neurosci. 2009, 148:5-15.
42. Fox C.S., Massaro J.M., Hoffmann U., Pou K.M., Maurovich-Horvat P., Liu C.Y., Vasan R.S., Murabito J.M., Meigs J.B., Cupples L.A., D'Agostino R.B., O'Donnell C.J. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007, 116:39-48.
43. Fuente-Martin E., Garcia-Caceres C., Morselli E., Clegg D.J., Chowen J.A., Finan B., Brinton R.D., Tschop M.H. Estrogen, astrocytes and the neuroendocrine control of metabolism. Rev. Endocr. Metab. Disord. 2013, 14:331-338.
44. Fujita M., Hata A. Sex and age differences in the effect of obesity on incidence of hypertension in the Japanese population: a large historical cohort study. J. Am. Soc. Hypertens. 2014, 8:64-70.
45. Galipeau D., Verma S., McNeill J.H. Female rats are protected against fructose-induced changes in metabolism and blood pressure. Am. J. Physiol. Heart Circ. Physiol. 2002, 283:H2478-H2484.
46. Galipeau D.M., Yao L., McNeill J.H. Relationship among hyperinsulinemia, insulin resistance, and hypertension is dependent on sex. Am. J. Physiol. Heart Circ. Physiol. 2002, 283:H562-H567.
47. Gao Q., Horvath T.L. Cross-talk between estrogen and leptin signaling in the hypothalamus. Am. J. Physiol. Endocrinol. Metab. 2008, 294:E817-E826.
48. Gentile C.L., Orr J.S., Davy B.M., Davy K.P. Modest weight gain is associated with sympathetic neural activation in nonobese humans. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 292:R1834-R1838.
49. Grassi G., Seravalle G., Dell'Oro R., Trevano F.Q., Bombelli M., Scopelliti F., Facchini A., Mancia G. Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: results of the CROSS study. J. Hypertens. 2003, 21:1761-1769.
50. Grassi G., Dell'Oro R., Facchini A., Quarti T.F., Bolla G.B., Mancia G. Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives. J. Hypertens. 2004, 22:2363-2369.
51. Grove K.L., Fried S.K., Greenberg A.S., Xiao X.Q., Clegg D.J. A microarray analysis of sexual dimorphism of adipose tissues in high-fat-diet-induced obese mice. Int. J. Obes. (Lond) 2010, 34:989-1000.
52. Guerre-Millo M., Leturque A., Girard J., Lavau M. Increased insulin sensitivity and responsiveness of glucose metabolism in adipocytes from female versus male rats. J. Clin. Invest. 1985, 76:109-116.
53. Gupte M., Thatcher S.E., Boustany-Kari C.M., Shoemaker R., Yiannikouris F., Zhang X., Karounos M., Cassis L.A. Angiotensin converting enzyme 2 contributes to sex differences in the development of obesity hypertension in C57BL/6 mice. Arterioscler. Thromb. Vasc. Biol. 2012, 32:1392-1399.
54. Hall J.E., da Silva A.A., do Carmo J.M., Dubinion J., Hamza S., Munusamy S., Smith G., Stec D.E. Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins. J. Biol. Chem. 2010, 285:17271-17276.
55. Hallschmid M., Benedict C., Schultes B., Fehm H.L., Born J., Kern W. Intranasal insulin reduces body fat in men but not in women. Diabetes 2004, 53:3024-3029.
56. Hallschmid M., Benedict C., Schultes B., Perras B., Fehm H.L., Kern W., Born J. Towards the therapeutic use of intranasal neuropeptide administration in metabolic and cognitive disorders. Regul. Pept. 2008, 149:79-83.
57. Hart E.C., Charkoudian N., Wallin B.G., Curry T.B., Eisenach J.H., Joyner M.J. Sex differences in sympathetic neural-hemodynamic balance: implications for human blood pressure regulation. Hypertension 2009, 53:571-576.
58. Hart E.C., Charkoudian N., Wallin B.G., Curry T.B., Eisenach J., Joyner M.J. Sex and ageing differences in resting arterial pressure regulation: the role of the beta-adrenergic receptors. J. Physiol. 2011, 589:5285-5297.
59. He H., Ni Y., Chen J., Zhao Z., Zhong J., Liu D., Yan Z., Zhang W., Zhu Z. Sex difference in cardiometabolic risk profile and adiponectin expression in subjects with visceral fat obesity. Transl. Res. 2010, 155:71-77.
60. Hoffman D.J., Wang Z., Gallagher D., Heymsfield S.B. Comparison of visceral adipose tissue mass in adult African Americans and whites. Obes. Res. 2005, 13:66-74.
61. Hogarth A.J., Mackintosh A.F., Mary D.A. Gender-related differences in the sympathetic vasoconstrictor drive of normal subjects. Clin. Sci. (Lond.) 2007, 112:353-361.
62. Illum L. Nasal drug delivery: new developments and strategies. Drug Discov. Today 2002, 7:1184-1189.
63. Jerez S., Scacchi F., Sierra L., Karbiner S., de Bruno M.P. Vascular hyporeactivity to angiotensin II and noradrenaline in a rabbit model of obesity. J. Cardiovasc. Pharmacol. 2012, 59:49-57.
64. Ji H., Zheng W., Li X., Liu J., Wu X., Zhang M.A., Umans J.G., Hay M., Speth R.C., Dunn S.E., Sandberg K. Sex-specific T-cell regulation of angiotensin II-dependent hypertension. Hypertension 2014, 64:573-582.
65. Kaiyala K.J., Prigeon R.L., Kahn S.E., Woods S.C., Schwartz M.W. Obesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs. Diabetes 2000, 49:1525-1533.
66. Karastergiou K., Smith S.R., Greenberg A.S., Fried S.K. Sex differences in human adipose tissues - the biology of pear shape. Biol. Sex Differ. 2012, 3:13.
67. Kelly M.J., Qiu J. Estrogen signaling in hypothalamic circuits controlling reproduction. Brain Res. 2010, 1364:44-52.
68. Kern P.A., Di Gregorio G.B., Lu T., Rassouli N., Ranganathan G. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 2003, 52:1779-1785.
69. Kern W., Benedict C., Schultes B., Plohr F., Moser A., Born J., Fehm H.L., Hallschmid M. Low cerebrospinal fluid insulin levels in obese humans. Diabetologia 2006, 49:2790-2792.
70. Kneale B.J., Chowienczyk P.J., Brett S.E., Coltart D.J., Ritter J.M. Gender differences in sensitivity to adrenergic agonists of forearm resistance vasculature. J. Am. Coll. Cardiol. 2000, 36:1233-1238.
71. Koh K.K., Park S.M., Quon M.J. Leptin and cardiovascular disease: response to therapeutic interventions. Circulation 2008, 117:3238-3249.
72. Krug R., Benedict C., Born J., Hallschmid M. Comparable sensitivity of postmenopausal and young women to the effects of intranasal insulin on food intake and working memory. J. Clin. Endocrinol. Metab. 2010, 95:E468-E472.
73. Lambert E., Straznicky N., Eikelis N., Esler M., Dawood T., Masuo K., Schlaich M., Lambert G. Gender differences in sympathetic nervous activity: influence of body mass and blood pressure. J. Hypertens. 2007, 25:1411-1419.
74. Lambert E., Sari C.I., Dawood T., Nguyen J., McGrane M., Eikelis N., Chopra R., Wong C., Chatzivlastou K., Head G., Straznicky N., Esler M., Schlaich M., Lambert G. Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults. Hypertension 2010, 56:351-358.
75. Lambert G.W., Straznicky N.E., Lambert E.A., Dixon J.B., Schlaich M.P. Sympathetic nervous activation in obesity and the metabolic syndrome-causes, consequences and therapeutic implications. Pharmacol. Ther. 2010, 126:159-172.
76. Limberg J.K., Morgan B.J., Sebranek J.J., Proctor L.T., Walker B.J., Eldridge M.W., Schrage W.G. Altered neurovascular control of the resting circulation in human metabolic syndrome. J. Physiol. 2012, 590:6109-6119.
77. Limberg J.K., Curry T.B., Prabhakar N.R., Joyner M.J. Is insulin the new intermittent hypoxia?. Med. Hypotheses 2014, 82:730-735.
78. Liu J., Fox C.S., Hickson D.A., May W.D., Hairston K.G., Carr J.J., Taylor H.A. Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson Heart Study. J. Clin. Endocrinol. Metab. 2010, 95:5419-5426.
79. Liu J., Coady S., Carr J.J., Hoffmann U., Taylor H.A., Fox C.S. Differential associations of abdominal visceral, subcutaneous adipose tissue with cardiometabolic risk factors between African and European Americans. Obesity (Silver Spring) 2014, 22:811-818.
80. Lovejoy J.C., Sainsbury A. Sex differences in obesity and the regulation of energy homeostasis. Obes. Rev. 2009, 10:154-167.
81. Machleidt F., Simon P., Krapalis A.F., Hallschmid M., Lehnert H., Sayk F. Experimental hyperleptinemia acutely increases vasoconstrictory sympathetic nerve activity in healthy humans. J. Clin. Endocrinol. Metab. 2013, 98:E491-E496.
82. Macotela Y., Boucher J., Tran T.T., Kahn C.R. Sex and depot differences in adipocyte insulin sensitivity and glucose metabolism. Diabetes 2009, 58:803-812.
83. Mallamaci F., Cuzzola F., Tripepi G., Cutrupi S., Parlongo S., Tripepi R., Zoccali C. Gender-dependent differences in plasma leptin in essential hypertension. Am. J. Hypertens. 2000, 13:914-920.
84. Maqbool A., West R.M., Galloway S.L., Drinkhill M.J., Mary D.A., Greenwood J.P., Ball S.G. Resting sympathetic nerve activity is related to age, sex and arterial pressure but not to alpha2-adrenergic receptor subtype. J. Hypertens. 2010, 28:2084-2093.
85. Marinik E.L., Frisard M.I., Hulver M.W., Davy B.M., Rivero J.M., Savla J.S., Davy K.P. Angiotensin II receptor blockade and insulin sensitivity in overweight and obese adults with elevated blood pressure. Ther. Adv. Cardiovasc. Dis. 2013, 7:11-20.
86. Mark A.L. Selective leptin resistance revisited. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2013, 305:R566-R581.
87. Mauvais-Jarvis F., Clegg D.J., Hevener A.L. The role of estrogens in control of energy balance and glucose homeostasis. Endocr. Rev. 2013, 34:309-338.
88. Minson C.T., Halliwill J.R., Young T.M., Joyner M.J. Influence of the menstrual cycle on sympathetic activity, baroreflex sensitivity, and vascular transduction in young women. Circulation 2000, 101:862-868.
89. Morgan D.A., Balon T.W., Ginsberg B.H., Mark A.L. Nonuniform regional sympathetic nerve responses to hyperinsulinemia in rats. Am. J. Physiol. 1993, 264:R423-R427.
90. Muntzel M.S., Al Naimi O.A., Barclay A., Ajasin D. Cafeteria diet increases fat mass and chronically elevates lumbar sympathetic nerve activity in rats. Hypertension 2012, 60:1498-1502.
91. Narkiewicz K., Phillips B.G., Kato M., Hering D., Bieniaszewski L., Somers V.K. Gender-selective interaction between aging, blood pressure, and sympathetic nerve activity. Hypertension 2005, 45:522-525.
92. Nedogoda S.V., Ledyaeva A.A., Chumachok E.V., Tsoma V.V., Mazina G., Salasyuk A.S., Barykina I.N. Randomized trial of perindopril, enalapril, losartan and telmisartan in overweight or obese patients with hypertension. Clin. Drug Investig. 2013, 33:553-561.
93. Ng A.V., Callister R., Johnson D.G., Seals D.R. Age and gender influence muscle sympathetic nerve activity at rest in healthy humans. Hypertension 1993, 21:498-503.
94. Plut C., Ribiere C., Giudicelli Y., Dausse J.P. Gender differences in hypothalamic tyrosine hydroxylase and alpha(2)-adrenoceptor subtype gene expression in cafeteria diet-induced hypertension and consequences of neonatal androgenization. J. Pharmacol. Exp. Ther. 2002, 302:525-531.
95. Pollow D.P., Uhrlaub J., Romero-Aleshire M.J., Sandberg K., Nikolich-Zugich J., Brooks H.L., Hay M. Sex differences in T-lymphocyte tissue infiltration and development of angiotensin II hypertension. Hypertension 2014, 64:384-390.
96. Power M.L., Schulkin J. Sex differences in fat storage, fat metabolism, and the health risks from obesity: possible evolutionary origins. Br. J. Nutr. 2008, 99:931-940.
97. Purkayastha S., Zhang G., Cai D. Uncoupling the mechanisms of obesity and hypertension by targeting hypothalamic IKK-beta and NF-kappaB. Nat. Med. 2011, 17:883-887.
98. Rahmouni K. Leptin-induced sympathetic nerve activation: signaling mechanisms and cardiovascular consequences in obesity. Curr. Hypertens. Rev. 2010, 6:104-209.
99. Richard D., Monge-Roffarello B., Chechi K., Labbe S.M., Turcotte E.E. Control and physiological determinants of sympathetically mediated brown adipose tissue thermogenesis. Front. Endocrinol. (Lausanne) 2012, 3:36.
100. Roberts C.K., Vaziri N.D., Barnard R.J. Protective effects of estrogen on gender-specific development of diet-induced hypertension. J. Appl. Physiol. (1985) 2001, 91:2005-2009.
101. Rogers J.L., Mitchell A.R., Maric C., Sandberg K., Myers A., Mulroney S.E. Effect of sex hormones on renal estrogen and angiotensin type 1 receptors in female and male rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 292:R794-R799.
102. Romanko O.P., Stepp D.W. Reduced constrictor reactivity balances impaired vasodilation in the mesenteric circulation of the obese Zucker rat. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:H2097-H2102.
103. Saleh M.C., Connell B.J., Saleh T.M. Autonomic and cardiovascular reflex responses to central estrogen injection in ovariectomized female rats. Brain Res. 2000, 879:105-114.
104. Sandberg K., Ji H. Sex differences in primary hypertension. Biol. Sex Differ. 2012, 3:7.
105. Schlaich M.P., Grassi G., Lambert G.W., Straznicky N., Esler M.D., Dixon J., Lambert E.A., Redon J., Narkiewicz K., Jordan J. European Society of Hypertension Working Group on Obesity Obesity-induced hypertension and target organ damage: current knowledge and future directions. J. Hypertens. 2009, 27:207-211.
106. Schmitt J.A., Joyner M.J., Charkoudian N., Wallin B.G., Hart E.C. Sex differences in alpha-adrenergic support of blood pressure. Clin. Auton. Res. 2010, 20:271-275.
107. Seals D.R., Esler M.D. Human ageing and the sympathoadrenal system. J. Physiol. 2000, 528:407-417.
108. Senador D., Kanakamedala K., Irigoyen M.C., Morris M., Elased K.M. Cardiovascular and autonomic phenotype of db/db diabetic mice. Exp. Physiol. 2009, 94:648-658.
109. Sheu W.H., Lee W.J., Chen Y.T. High plasma leptin concentrations in hypertensive men but not in hypertensive women. J. Hypertens. 1999, 17:1289-1295.
110. Shi Z., Brooks V.L. Leptin differentially increases sympathetic nerve activity and its baroreflex regulation in female rats: role of estrogen. J. Physiol. 2014, (in press).
111. Sivitz W.I., Wayson S.M., Bayless M.L., Sinkey C.A., Haynes W.G. Obesity impairs vascular relaxation in human subjects: hyperglycemia exaggerates adrenergic vasoconstriction arterial dysfunction in obesity and diabetes. J. Diabetes Complications 2007, 21:149-157.
112. Smith M.M., Minson C.T. Obesity and adipokines: effects on sympathetic overactivity. J. Physiol. 2012, 590:1787-1801.
113. Straznicky N.E., Lambert G.W., Masuo K., Dawood T., Eikelis N., Nestel P.J., McGrane M.T., Mariani J.A., Socratous F., Chopra R., Esler M.D., Schlaich M.P., Lambert E.A. Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome. Am. J. Clin. Nutr. 2009, 89:27-36.
114. Sugiyama M.G., Agellon L.B. Sex differences in lipid metabolism and metabolic disease risk. Biochem. Cell Biol. 2012, 90:124-141.
115. Tamaya-Mori N., Uemura K., Iguchi A. Gender differences in the dietary lard-induced increase in blood pressure in rats. Hypertension 2002, 39:1015-1020.
116. Tank J., Heusser K., Diedrich A., Hering D., Luft F.C., Busjahn A., Narkiewicz K., Jordan J. Influences of gender on the interaction between sympathetic nerve traffic and central adiposity. J. Clin. Endocrinol. Metab. 2008, 93:4974-4978.
117. Tchernof A., Despres J.P. Pathophysiology of human visceral obesity: an update. Physiol. Rev. 2013, 93:359-404.
118. Thaler J.P., Schwartz M.W. Minireview: inflammation and obesity pathogenesis: the hypothalamus heats up. Endocrinology 2010, 151:4109-4115.
119. Thorne R.G., Pronk G.J., Padmanabhan V., Frey W.H. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience 2004, 127:481-496.
120. Vollenweider P., Randin D., Tappy L., Jequier E., Nicod P., Scherrer U. Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. J. Clin. Invest. 1994, 93:2365-2371.
121. Vongpatanasin W., Tuncel M., Mansour Y., Arbique D., Victor R.G. Transdermal estrogen replacement therapy decreases sympathetic activity in postmenopausal women. Circulation 2001, 103:2903-2908.
122. Ward K.R., Bardgett J.F., Wolfgang L., Stocker S.D. Sympathetic response to insulin is mediated by melanocortin 3/4 receptors in the hypothalamic paraventricular nucleus. Hypertension 2011, 57:435-441.
123. Weitz G., Elam M., Born J., Fehm H.L., Dodt C. Postmenopausal estrogen administration suppresses muscle sympathetic nerve activity. J. Clin. Endocrinol. Metab. 2001, 86:344-348.
124. Wu Z., Maric C., Roesch D.M., Zheng W., Verbalis J.G., Sandberg K. Estrogen regulates adrenal angiotensin AT1 receptors by modulating AT1 receptor translation. Endocrinology 2003, 144:3251-3261.
125. Xue B., Johnson A.K., Hay M. Sex differences in angiotensin II- and aldosterone-induced hypertension: the central protective effects of estrogen. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2013, 305:R459-R463.
126. Young C.N., Deo S.H., Chaudhary K., Thyfault J.P., Fadel P.J. Insulin enhances the gain of arterial baroreflex control of muscle sympathetic nerve activity in humans. J. Physiol. 2010, 588:3593-3603.